Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Clobetasol"" wg kryterium: Temat


Tytuł :
Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial.
Autorzy :
Jatoi A; Mayo Clinic, Rochester, Minnesota, USA.
Ou FS; Mayo Clinic, Rochester, Minnesota, USA.
Ahn DH; Mayo Clinic, Scottsdale, Arizona, USA.
Zemla TJ; Mayo Clinic, Rochester, Minnesota, USA.
Le-Rademacher JG; Mayo Clinic, Rochester, Minnesota, USA.
Boland P; Roswell Park Cancer Institute, Buffalo, New York, USA.
Ciombor KK; Vanderbilt University, Nashville, Tennessee, USA.
Jacobs NL; Minnesota Hematology Oncology, Coon Rapids, Minnesota, USA.
Pasche B; Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, USA.
Cleary JM; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
McCune JS; City of Hope, Duarte, California, USA.
Pedersen KS; Washington University in St. Louis, St. Louis, Missouri, USA.
Barzi A; City of Hope, Duarte, California, USA.
Chiorean EG; University of Washington, Seattle, Washington, USA.
Heying EN; Mayo Clinic, Rochester, Minnesota, USA.
Lenz HJ; USC Norris Comprehensive Cancer Center, California, Los Angeles, USA.
Sloan JA; Mayo Clinic, Rochester, Minnesota, USA.
Grothey A; West Cancer Center, Germantown, Tennessee, USA.
Lacouture ME; Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Bekaii-Saab T; Mayo Clinic, Scottsdale, Arizona, USA.
Pokaż więcej
Źródło :
The oncologist [Oncologist] 2021 Jul; Vol. 26 (7), pp. 610-618. Date of Electronic Publication: 2021 Mar 06.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Clobetasol*/therapeutic use
Hand-Foot Syndrome*/drug therapy
Hand-Foot Syndrome*/etiology
Hand-Foot Syndrome*/prevention & control
Activities of Daily Living ; Humans ; Phenylurea Compounds ; Pyridines ; Quality of Life
Czasopismo naukowe
Tytuł :
Clobetasol Compared With Fractionated Carbon Dioxide Laser for Lichen Sclerosus: A Randomized Controlled Trial.
Autorzy :
Burkett LS; Department of Obstetrics and Gynecology, Section of Female Pelvic Medicine and Reconstructive Surgery, MedStar Washington Hospital Center and Georgetown University School of Medicine, Washington, DC; the Department of Biostatistics, Medstar Health Research Institute, Hyattsville, Maryland; the Department of Obstetrics and Gynecology, Magee-Womens Hospital, University of Pittsburgh Health System, Pittsburgh, Pennsylvania; the Department of Urogynecology, Brown Women & Infants Hospital of Rhode Island, Providence, Rhode Island; and the Department of Subspecialty Care for Women's Health, Cleveland Clinic, Cleveland, Ohio.
Siddique M
Zeymo A
Brunn EA
Gutman RE
Park AJ
Iglesia CB
Pokaż więcej
Źródło :
Obstetrics and gynecology [Obstet Gynecol] 2021 Jun 01; Vol. 137 (6), pp. 968-978.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Inflammatory Agents/*therapeutic use
Clobetasol/*therapeutic use
Lasers, Gas/*therapeutic use
Vulvar Lichen Sclerosus/*therapy
Administration, Topical ; Aged ; Anti-Inflammatory Agents/administration & dosage ; Anti-Inflammatory Agents/adverse effects ; Clobetasol/administration & dosage ; Clobetasol/adverse effects ; Female ; Humans ; Lasers, Gas/adverse effects ; Middle Aged ; Patient Satisfaction ; Retreatment ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology.
Autorzy :
Tanghetti EA; Center for Dermatology and Laser Surgery, Columbia University, Sacramento, CA, USA.
Stein Gold L; Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA.
Del Rosso JQ; JDR Dermatology Research/Thomas Dermatology, Las Vegas, NV, USA.
Lin T; Ortho Dermatologics, Bridgewater, NJ, USA.
Angel A; Bausch Health Americas, Inc., Petaluma, CA, USA.
Pillai R; Bausch Health Americas, Inc., Petaluma, CA, USA.
Pokaż więcej
Źródło :
The Journal of dermatological treatment [J Dermatolog Treat] 2021 Jun; Vol. 32 (4), pp. 391-398. Date of Electronic Publication: 2019 Sep 26.
Typ publikacji :
Journal Article
MeSH Terms :
Clobetasol/*analogs & derivatives
Nicotinic Acids/*administration & dosage
Psoriasis/*drug therapy
Clobetasol/administration & dosage ; Dermatologic Agents/therapeutic use ; Drug Combinations ; Emulsions ; Humans ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Once-Daily Halobetasol Propionate 0.01% Lotion for Moderate-to-Severe Plaque Psoriasis: Phase 3 Analysis of Hispanic Participants.
Autorzy :
Desai SR
Glick B
Del Rosso JQ
Harris S
Jacobson A
Pokaż więcej
Źródło :
Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2021 Mar 01; Vol. 20 (3), pp. 252-258.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Clobetasol/*analogs & derivatives
Dermatitis, Contact/*epidemiology
Dermatologic Agents/*administration & dosage
Psoriasis/*drug therapy
Vasoconstrictor Agents/*administration & dosage
Administration, Cutaneous ; Adult ; Clobetasol/administration & dosage ; Clobetasol/adverse effects ; Dermatitis, Contact/etiology ; Dermatologic Agents/adverse effects ; Double-Blind Method ; Drug Administration Schedule ; Female ; Hispanic Americans ; Humans ; Male ; Middle Aged ; Psoriasis/diagnosis ; Severity of Illness Index ; Treatment Outcome ; Vasoconstrictor Agents/adverse effects
Czasopismo naukowe
Tytuł :
Topical delivery of clobetasol propionate loaded nanosponge hydrogel for effective treatment of psoriasis: Formulation, physicochemical characterization, antipsoriatic potential and biochemical estimation.
Autorzy :
Kumar S; Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar 125001, Haryana, India.
Prasad M; Department of Animal Biotechnology, Lala Lajpat Rai University of Veterinary and Animal Sciences, Hisar 125004, Haryana, India.
Rao R; Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar 125001, Haryana, India. Electronic address: .
Pokaż więcej
Źródło :
Materials science & engineering. C, Materials for biological applications [Mater Sci Eng C Mater Biol Appl] 2021 Feb; Vol. 119, pp. 111605. Date of Electronic Publication: 2020 Oct 09.
Typ publikacji :
Journal Article
MeSH Terms :
Clobetasol*/metabolism
Clobetasol*/therapeutic use
Psoriasis*/drug therapy
Psoriasis*/metabolism
Administration, Topical ; Animals ; Drug Liberation ; Hydrogels ; Mice ; Skin/metabolism
Czasopismo naukowe
Tytuł :
Topical 0.05% clobetasol cream in the treatment of chronic hand eczema: A protocol for systematic review and meta-analysis.
Autorzy :
Jing M; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, P. R. China.
Yu Q
Zhu B
Yuan F
Zhang J
Peng L
Lin W
Chen M
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Mar 12; Vol. 100 (10), pp. e24418.
Typ publikacji :
Journal Article
MeSH Terms :
Clobetasol/*administration & dosage
Eczema/*drug therapy
Hand Dermatoses/*drug therapy
Pruritus/*drug therapy
Skin Cream/*administration & dosage
Chronic Disease/drug therapy ; Clobetasol/adverse effects ; Eczema/complications ; Eczema/diagnosis ; Hand Dermatoses/complications ; Hand Dermatoses/diagnosis ; Humans ; Meta-Analysis as Topic ; Pruritus/diagnosis ; Pruritus/etiology ; Quality of Life ; Randomized Controlled Trials as Topic ; Severity of Illness Index ; Skin Cream/adverse effects ; Systematic Reviews as Topic ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Successful Treatment of Lichen Amyloidosis Using a Fixed Combination of Halobetasol-Propionate and Tazarotene Lotion.
Autorzy :
Shoen E
Hou A
Zahn J
Friedman A
Pokaż więcej
Źródło :
Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2021 Mar 01; Vol. 20 (3), pp. 336-337.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Amyloidosis/*drug therapy
Clobetasol/*analogs & derivatives
Nicotinic Acids/*administration & dosage
Skin Cream/*administration & dosage
Amyloidosis/diagnosis ; Amyloidosis/pathology ; Biopsy ; Clobetasol/administration & dosage ; Drug Combinations ; Humans ; Male ; Middle Aged ; Skin/drug effects ; Skin/pathology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Iatrogenic hypercortisolism in a Persian kitten after topical application of a skin lotion containing clobetasol.
Autorzy :
Chirayath D; Department of Veterinary Clinical Medicine, Ethics & Jurisprudence, College of Veterinary and Animal Sciences, Mannuthy, Kerala Veterinary and Animal Sciences University, Thrissur, Kerala, 680 651, India.
Shaheena S; Department of Veterinary Clinical Medicine, Ethics & Jurisprudence, College of Veterinary and Animal Sciences, Mannuthy, Kerala Veterinary and Animal Sciences University, Thrissur, Kerala, 680 651, India.
Pokaż więcej
Źródło :
Veterinary dermatology [Vet Dermatol] 2020 Dec; Vol. 31 (6), pp. 486-488. Date of Electronic Publication: 2020 Oct 07.
Typ publikacji :
Case Reports
MeSH Terms :
Cat Diseases*
Clobetasol*/administration & dosage
Clobetasol*/adverse effects
Cushing Syndrome*/veterinary
Glucocorticoids*/administration & dosage
Glucocorticoids*/adverse effects
Administration, Topical ; Animals ; Cats ; Female ; Iatrogenic Disease/veterinary ; Skin Cream
Raport
Tytuł :
Psoriasis improvement and satisfaction in patients using a clobetasol spray and oral apremilast combination regimen: A pilot study.
Autorzy :
Wei C; Department of Dermatology, The George Washington School of Medicine and Health Sciences, Washington, DC; The George Washington School of Medicine and Health Sciences, Washington, DC.
Friedman AJ; Department of Dermatology, The George Washington School of Medicine and Health Sciences, Washington, DC.
Prussick RB; Department of Dermatology, The George Washington School of Medicine and Health Sciences, Washington, DC. Electronic address: .
Pokaż więcej
Źródło :
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Oct; Vol. 83 (4), pp. 1198-1200. Date of Electronic Publication: 2020 Feb 21.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Clobetasol/*therapeutic use
Phosphodiesterase 4 Inhibitors/*therapeutic use
Psoriasis/*drug therapy
Thalidomide/*analogs & derivatives
Administration, Oral ; Aerosols ; Clobetasol/administration & dosage ; Drug Therapy, Combination ; Female ; Humans ; Male ; Patient Satisfaction ; Phosphodiesterase 4 Inhibitors/administration & dosage ; Pilot Projects ; Prospective Studies ; Thalidomide/administration & dosage ; Thalidomide/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Successful Management of a Black Male With Psoriasis and Dyspigmentation Treated With Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion: Case Report
Autorzy :
Desai SR
Alexis AF
Jacobson A
Pokaż więcej
Źródło :
Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2020 Oct 01; Vol. 19 (10), pp. 1000-1004.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Clobetasol/*analogs & derivatives
Hypopigmentation/*drug therapy
Nicotinic Acids/*administration & dosage
Psoriasis/*drug therapy
Skin Cream/*administration & dosage
Administration, Cutaneous ; African Americans ; Clobetasol/administration & dosage ; Drug Combinations ; Esthetics ; Humans ; Hypopigmentation/diagnosis ; Hypopigmentation/immunology ; Male ; Middle Aged ; Psoriasis/complications ; Psoriasis/diagnosis ; Psoriasis/immunology ; Severity of Illness Index ; Skin Pigmentation/drug effects ; Skin Pigmentation/immunology ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials.
Autorzy :
Ramachandran V; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.; Baylor College of Medicine, Houston, Texas, USA.
Bertus B; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Bashyam AM; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Feldman SR; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.; Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC, USA.; Department of Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA.; Department of Dermatology, University of Southern Denmark, Odense, Denmark.
Pokaż więcej
Źródło :
The Annals of pharmacotherapy [Ann Pharmacother] 2020 Sep; Vol. 54 (9), pp. 872-878. Date of Electronic Publication: 2020 Mar 04.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Clobetasol/*analogs & derivatives
Dermatologic Agents/*therapeutic use
Nicotinic Acids/*therapeutic use
Psoriasis/*drug therapy
Administration, Cutaneous ; Adult ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Clobetasol/administration & dosage ; Clobetasol/adverse effects ; Clobetasol/therapeutic use ; Dermatologic Agents/administration & dosage ; Dermatologic Agents/adverse effects ; Drug Combinations ; Drug Synergism ; Humans ; Nicotinic Acids/administration & dosage ; Nicotinic Acids/adverse effects ; Pain/chemically induced ; Pruritus/chemically induced ; Severity of Illness Index ; Skin Cream ; Treatment Outcome ; United States
Czasopismo naukowe
Tytuł :
Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants.
Autorzy :
Cook-Bolden FE
Hebert AA
Guenthner ST
Kang R
Martin G
Jacobson A
Pokaż więcej
Źródło :
Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2020 Aug 01; Vol. 19 (8), pp. 747-754.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms :
Clobetasol/*analogs & derivatives
Dermatologic Agents/*administration & dosage
Psoriasis/*drug therapy
Skin Cream/*administration & dosage
Adult ; Aged ; Clobetasol/administration & dosage ; Clobetasol/adverse effects ; Dermatologic Agents/adverse effects ; Double-Blind Method ; Drug Administration Schedule ; Female ; Humans ; Male ; Middle Aged ; Psoriasis/diagnosis ; Severity of Illness Index ; Sex Factors ; Skin Cream/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Nanostructured lipid carriers loaded with Halobetasol propionate for topical treatment of inflammation: Development, characterization, biopharmaceutical behavior and therapeutic efficacy of gel dosage forms.
Autorzy :
Carvajal-Vidal P; Pharmacy, Pharmaceutical Technology and Physical Chemistry Department, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. de Joan XXIII, 27-31, 08028 Barcelona, Spain; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain.
González-Pizarro R; Pharmacy, Pharmaceutical Technology and Physical Chemistry Department, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. de Joan XXIII, 27-31, 08028 Barcelona, Spain; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain; National Drug Agency Department (ANAMED), Institute of Public Health (ISP), Av. Marathon 1000, Ñuñoa, 7780050 Santiago, Chile.
Araya C; Pharmacy, Pharmaceutical Technology and Physical Chemistry Department, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. de Joan XXIII, 27-31, 08028 Barcelona, Spain; Bussiness Manufacturing Company of Ecuador, Av Republica E3-33, 170103 Quito, Ecuador.
Espina M; Pharmacy, Pharmaceutical Technology and Physical Chemistry Department, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. de Joan XXIII, 27-31, 08028 Barcelona, Spain; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain.
Halbaut L; Pharmacy, Pharmaceutical Technology and Physical Chemistry Department, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. de Joan XXIII, 27-31, 08028 Barcelona, Spain.
Gómez de Aranda I; Pathology and Experimental Therapeutics Department. Faculty of Medicine and Health Sciences. Bellvitge Campus. University of Barcelona, Av. Mare de Déu de Bellvitge, 3, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
García ML; Pharmacy, Pharmaceutical Technology and Physical Chemistry Department, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. de Joan XXIII, 27-31, 08028 Barcelona, Spain; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain. Electronic address: .
Calpena AC; Pharmacy, Pharmaceutical Technology and Physical Chemistry Department, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. de Joan XXIII, 27-31, 08028 Barcelona, Spain; Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona, 08028 Barcelona, Spain.
Pokaż więcej
Źródło :
International journal of pharmaceutics [Int J Pharm] 2020 Jul 30; Vol. 585, pp. 119480. Date of Electronic Publication: 2020 May 29.
Typ publikacji :
Journal Article
MeSH Terms :
Biological Products/*chemical synthesis
Clobetasol/*analogs & derivatives
Drug Carriers/*chemical synthesis
Drug Development/*methods
Inflammation/*drug therapy
Nanostructures/*chemistry
Administration, Topical ; Adult ; Animals ; Biological Products/administration & dosage ; Biological Products/metabolism ; Clobetasol/administration & dosage ; Clobetasol/chemical synthesis ; Clobetasol/metabolism ; Dosage Forms ; Drug Carriers/administration & dosage ; Drug Carriers/metabolism ; Female ; Gels ; Humans ; Inflammation/metabolism ; Lipids ; Male ; Middle Aged ; Nanostructures/administration & dosage ; Organ Culture Techniques ; Rabbits ; Skin Absorption/drug effects ; Skin Absorption/physiology ; Treatment Outcome ; Vasoconstrictor Agents/administration & dosage ; Vasoconstrictor Agents/chemical synthesis ; Vasoconstrictor Agents/metabolism
Czasopismo naukowe
Tytuł :
Determination of clobetasol propionate, tazarotene and tazarotenic acid in Bama mini-pig skin by UPLC-MS/MS: Application to pharmacokinetic and drug-drug interaction studies.
Autorzy :
Lu YT; Key Laboratory of Drug Quality Control and Pharmacovigilance (China Pharmaceutical University), Ministry of Education, Nanjing, China; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China.
Guan R; Key Laboratory of Drug Quality Control and Pharmacovigilance (China Pharmaceutical University), Ministry of Education, Nanjing, China; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China.
Zheng JR; Institute of Dermatology and Hospital for Skin Disease, Chinese Academy of Medical Sciences & Peking Union Medical Collage, Nanjing, China.
Hang TJ; Key Laboratory of Drug Quality Control and Pharmacovigilance (China Pharmaceutical University), Ministry of Education, Nanjing, China; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China. Electronic address: .
Song M; Key Laboratory of Drug Quality Control and Pharmacovigilance (China Pharmaceutical University), Ministry of Education, Nanjing, China; Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, China. Electronic address: .
Pokaż więcej
Źródło :
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2020 Jul 15; Vol. 186, pp. 113322. Date of Electronic Publication: 2020 Apr 23.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Chromatography, High Pressure Liquid/*methods
Clobetasol/*pharmacokinetics
Nicotinic Acids/*pharmacokinetics
Tandem Mass Spectrometry/*methods
Animals ; Clobetasol/administration & dosage ; Dermatologic Agents/administration & dosage ; Dermatologic Agents/pharmacokinetics ; Drug Interactions ; Female ; Male ; Nicotinic Acids/administration & dosage ; Skin/metabolism ; Swine ; Swine, Miniature
Czasopismo naukowe
Tytuł :
Photobiomodulation is effective in oral lichen planus: A randomized, controlled, double-blind study.
Autorzy :
Ferri EP; Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil.
Cunha KRL; Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil.
Abboud CS; Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil.
de Barros Gallo C; Department of Stomatology, School of Dentistry, University of São Paulo, São Paulo, Brazil.
de Sousa Sobral S; Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil.
de Fatima Teixeira da Silva D; Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil.
Horliana ACRT; Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil.
Franco AL; Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil.
Rodrigues MFSD; Postgraduate Program in Biophotonics Applied to Health Sciences, Nove de Julho University, UNINOVE, São Paulo, Brazil.
Pokaż więcej
Źródło :
Oral diseases [Oral Dis] 2021 Jul; Vol. 27 (5), pp. 1205-1216. Date of Electronic Publication: 2020 Oct 26.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Lichen Planus, Oral*/drug therapy
Administration, Topical ; Clobetasol/therapeutic use ; Double-Blind Method ; Glucocorticoids/therapeutic use ; Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Safety and Efficacy of Clobetasol Propionate 0.05% Emollient Foam for the Treatment of Central Centrifugal Cicatricial Alopecia.
Autorzy :
Callender VD
Kazemi A
Young CM
Chappell JA
Sperling LC
Pokaż więcej
Źródło :
Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2020 Jul 01; Vol. 19 (7), pp. 719-724.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Alopecia/*drug therapy
Anti-Inflammatory Agents/*therapeutic use
Clobetasol/*therapeutic use
Emollients/*therapeutic use
Administration, Cutaneous ; Adult ; Aged ; Alopecia/pathology ; Anti-Inflammatory Agents/administration & dosage ; Clobetasol/administration & dosage ; Emollients/administration & dosage ; Female ; Humans ; Middle Aged ; Severity of Illness Index ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Halobetasol 0.01%/Tazarotene 0.045% Lotion for Moderate-to-Severe Psoriasis: Pooled Phase 3 Analysis of Males and Females.
Autorzy :
Stein Gold L
Elewski B
Draelos Z
Jacobson A
Lin T
Pokaż więcej
Źródło :
Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2020 May 01; Vol. 19 (5), pp. 504-514.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms :
Clobetasol/*analogs & derivatives
Nicotinic Acids/*administration & dosage
Psoriasis/*drug therapy
Skin Cream/*administration & dosage
Adult ; Aged ; Clobetasol/administration & dosage ; Clobetasol/adverse effects ; Dermatitis, Contact/epidemiology ; Dermatitis, Contact/etiology ; Double-Blind Method ; Drug Combinations ; Female ; Humans ; Male ; Middle Aged ; Nicotinic Acids/adverse effects ; Pain/epidemiology ; Pain/etiology ; Pruritus/epidemiology ; Pruritus/etiology ; Psoriasis/diagnosis ; Severity of Illness Index ; Sex Factors ; Skin Cream/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion for Moderate-to-Severe Psoriasis: Pooled Phase 3 Analysis of Lower Extremities.
Autorzy :
Tyring S
Kircik LH
Yamauchi P
Jacobson A
Lin T
Pokaż więcej
Źródło :
Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2020 Apr 01; Vol. 19 (4), pp. 389-396.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Clobetasol/*analogs & derivatives
Dermatologic Agents/*therapeutic use
Nicotinic Acids/*therapeutic use
Psoriasis/*drug therapy
Administration, Cutaneous ; Adult ; Clobetasol/administration & dosage ; Clobetasol/therapeutic use ; Dermatologic Agents/administration & dosage ; Double-Blind Method ; Drug Combinations ; Female ; Humans ; Leg ; Male ; Middle Aged ; Nicotinic Acids/administration & dosage ; Psoriasis/pathology ; Severity of Illness Index ; Treatment Outcome ; United States
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies